The role of macrophage polarization in infectious and inflammatory diseases

Molecules and Cells

Volumn 37, Issue 4, 2014, Pages 275-285

  Labonte, Adam C ^a   Tosello Trampont, Annie Carole ^a   Hahn, Young S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cancer; Infectious disease; M1 M2; Macrophage polarization; NASH obesity

Indexed keywords

ARGINASE 1; CCL1 CHEMOKINE; CD163 ANTIGEN; EOTAXIN 2; GAMMA INTERFERON; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; STAT6 PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CYTOKINE;

ANTIGEN PRESENTATION; BACTERIAL INFECTION; CANCER GROWTH; CELL POLARITY; CHLAMYDIASIS; CYTOKINE PRODUCTION; CYTOPATHOGENIC EFFECT; DIABETES MELLITUS; ENZYME ACTIVATION; HEPATITIS C; IMMUNE RESPONSE; INFECTION; INFLAMMATORY DISEASE; INFLUENZA A (H5N1); INSULIN DEPENDENT DIABETES MELLITUS; KUPFFER CELL; LISTERIA MONOCYTOGENES; MACROPHAGE; MACROPHAGE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM ULCERANS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PHENOTYPE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SALMONELLA TYPHIMURIUM; SARS CORONAVIRUS; SECOND MESSENGER; SHIGELLA FLEXNERI; SHORT SURVEY; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TH1 CELL; TH2 CELL; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; CELL DIFFERENTIATION; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM DISEASES; IMMUNOLOGY; INFLAMMATION; MOLECULARLY TARGETED THERAPY;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM DISEASES; INFECTION; INFLAMMATION; MACROPHAGES; MOLECULAR TARGETED THERAPY;

EID: 84901393470     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2014.2374     Document Type: Short Survey

References (161)

1. Alfano, M., Graziano, F., Genovese, L., and Poli, G. (2013). Macrophage polarization at the crossroad between HIV-1 infection and cancer development. Arterioscler. Throm. Vas. Biol. 33, 1145-1152.
2. Arranz, A., Doxaki, C., Vergadi, E., de la Torre, Y.M., Vaporidi, K., Lagoudaki, E.D., Ieronymaki, E., Androulidaki, A., Venihaki, M., Margioris, A.N., et al. (2012). Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc. Natl. Acad. Sci. USA 109, 9517-9522.
3. Avdic, S., Cao, J.Z., McSharry, B.P., Clancy, L.E., Brown, R., Steain, M., Gottlieb, D., Abendroth, A., and Slobedman, B. (2013). Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses. J. Virol. 87, 10273-1082.
4. Beck, A.H., Espinosa, I., Edris, B., Li, R., Montgomery, K., Zhu, S., Varma, S., Marinelli, R.J., van de Rijn, M., and West, R.B. (2009). The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin. Cancer Res. 15, 778-787.
5. Benoit, M., Desnues, B., and Mege, J.-L. (2008). Macrophage polarization in bacterial infections. J. Immunol. 181, 3733-3739.
6. Bieghs, V., Wouters, K., van Gorp, P.J., Gijbels, M.J.J., de Winther, M.P.J., Binder, C.J., Lütjohann, D., Febbraio, M., Moore, K.J., van Bilsen, M., et al. (2010). Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology 138, 2477-2486, 2486.e1-e3.
7. Biswas, S.K., and Mantovani, A. (2010). Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896.
8. Biswas, S.K., Gangi, L., Paul, S., Schioppa, T., Saccani, A., Sironi, M., Bottazzi, B., Doni, A., Vincenzo, B., Pasqualini, F., et al. (2006). A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 107, 2112-22. (Pubitemid 43289397)
9. Biswas, S.K., Sica, A., and Lewis, C.E. (2008). Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J. Immunol. 180, 2011-2017.
10. Bradshaw, E.M., Raddassi, K., Elyaman, W., Orban, T., Gottlieb, P. A., Kent, S.C., and Hafler, D.A. (2009). Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J. Immunol. 183, 4432-4439.
11. Burke, A.P., Kolodgie, F.D., Zieske, A., Fowler, D.R., Weber, D.K., Varghese, P.J., Farb, A., and Virmani, R. (2004). Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler. Throm. Vas. Biol. 24, 1266-1271. (Pubitemid 38880019)
12. Byles, V., Covarrubias, A.J., Ben-Sahra, I., Lamming, D.W., Sabatini, D.M., Manning, B.D., and Horng, T. (2013). The TSC-mTOR pathway regulates macrophage polarization. Nat. Commun. 4, 2834.
13. Cassetta, L., Cassol, E., and Poli, G. (2011). Macrophage polarization in health and disease. ScientificWorldJournal 11, 2391-2402.
14. Cassetta, L., Kajaste-Rudnitski, A., Coradin, T., Saba, E., Della Chiara, G., Barbagallo, M., Graziano, F., Alfano, M., Cassol, E., Vicenzi, E., et al. (2013). M1 polarization of human monocytederived macrophages restricts pre and postintegration steps of HIV-1 replication. AIDS 27, 1847-1856.
15. Cassol, E., Cassetta, L., Alfano, M., and Poli, G. (2010). Macrophage polarization and HIV-1 infection. J. Leukoc. Biol. 87, 599-608.
16. Cassol, E., Cassetta, L., Rizzi, C., Gabuzda, D., Alfano, M., and Poli, G. (2013). Dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin mediates HIV-1 infection of and transmission by M2a-polarized macrophages in vitro. AIDS 27, 707-716.
17. Chacón-Salinas, R., Serafín-López, J., Ramos-Payán, R., Méndez-Aragón, P., Hernández-Pando, R., Van Soolingen, D., Flores-Romo, L., Estrada-Parra, S., and Estrada-García, I. (2005). Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 140, 443-449.
18. Chan, G., Bivins-Smith, E.R., Smith, M.S., Smith, P.M., and Yurochko, A.D. (2008). Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J. Immunol. 181, 698-711.
19. Chang, N.C., Hung, S.I., Hwa, K.Y., Kato, I., Chen, J.E., Liu, C.H., and Chang, A.C. (2001). A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J. Biol. Chem. 276, 17497-17506.
20. Chihara, T., Hashimoto, M., Osman, A., Hiyoshi-Yoshidomi, Y., Suzu, I., Chutiwitoonchai, N., Hiyoshi, M., Okada, S., and Suzu, S. (2012). HIV-1 proteins preferentially activate anti-inflammatory M2-type macrophages. J. Immunol. 188, 3620-3627.
21. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A.S., and Obin, M.S. (2005). Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347-2355. (Pubitemid 41532523)
22. Coscia, M., Quaglino, E., Iezzi, M., Curcio, C., Pantaleoni, F., Riganti, C., Holen, I., Mönkkönen, H., Boccadoro, M., Forni, G., et al. (2010). Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. J. Cell. Mol. Med. 14, 2803-2815.
23. Coursey, T.G., Chen, P.W., and Niederkorn, J.Y. (2012). Abrogating TNF-α expression prevents bystander destruction of normal itssues diruing iNOS-mediated elimination of intraocular tumors. Cancer Res. 71, 2445-2454.
24. Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., and Szabo, G. (2011). Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54, 133-144.
25. Daley, J.M., Brancato, S.K., Thomay, A.A., Reichner, J.S., and Albina, J.E. (2009). The phenotype of murine wound macropha ges. J. Leukoc. Biol. 87, 59-67.
26. Davies, L.C., Jenkins, S.J., Allen, J.E., and Taylor, P.R. (2013). Tissue-resident macrophages. Nat. Immunol. 14, 986-995.
27. Day, C.P., and James, O.F. (1998). Steatohepatitis: a tale of two "hits"? Gastroenterology 114, 842-845.
28. Devaraj, S., Glaser, N., Griffen, S., Wang-Polagruto, J., Miguelino, E., and Jialal, I. (2006). Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 55, 774-779. (Pubitemid 43343235)
29. Diao, Y., Xin, Y., Zhou, Y., Li, N., Pan, X., Qi, S., Qi, Z., Xu, Y., Luo, L., Wan, H., et al. (2013). Extracellular polysaccharide from Bacillus sp. strain LBP32 prevents LPS-induced inflammation in RAW 264.7 macrophages by inhibiting NF-κB and MAPKs activation and ROS production. Int. Immunopharmacol. 18, 12-19.
30. Donlan, R., and Costerton, J. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167-193. (Pubitemid 34303762)
31. Duffield, J. (2005). Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56-65.
32. Duluc, D., Corvaisier, M., Blanchard, S., Catala, L., Descamps, P., Gamelin, E., Ponsoda, S., Delneste, Y, Hebbar, M., and Jeannin, P. (2009). Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int. J. Cancer 125, 367-373.
33. Dumont, P., Berton, A., Nagy, N., Sandras, F., Tinton, S., Demetter, P., Mascart, F., Allaoui, A., Decaestecker, C., and Salmon, I. (2008). Expression of galectin-3 in the tumor immune response in colon cancer. Lab. Invest. 88, 896-906.
34. Eguchi, J., Kong, X., Tenta, M., Wang, X., Kang, S., and Rosen, E. D. (2013). Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization. Diabetes 62, 3394-3403.
35. Eisele, N.A, Ruby, T., Jacobson, A., Manzanillo, P.S., Cox, J.S., Lam, L., Mukundan, L., Chawla, A., and Monack, D.M. (2013). Salmonella require the fatty acid regulator PPAR? for the establishment of a metabolic environment essential for long-term persistence. Cell Host Microbe 14, 171-182.
36. Farrell, G.C., Chitturi, S., Gan, L., and van Rooyen, D. (2012). NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 6, 149-171.
37. Fenyo, I.M., and Gafencu, A.V. (2013). The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis. Immunobiology 218, 1376-1384.
38. Fletcher, N., Sutaria, R., Jo, J., and Barnes, A. (2013). Activated macro- phages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology (in press).
39. Förster, S., Brandt, M., Mottok, D.S., Zschüttig, A., Zimmermann, K., Blattner, F.R., Gunzer, F., and Pöhlmann, C. (2013). Secretory expression of biologically active human Herpes virus interleukin-10 analogues in Escherichia coli via a modified Sec-dependent transporter construct. BMC Biotechnol., 13, 82.
40. Franks, T.J., Chong, P.Y., Chui, P., Galvin, J.R., Lourens, R.M., Reid, A.H., Selbs, E., Mcevoy, P.L., Hayden, D.L., Fukuoka, J., et al. (2003). Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum. Pathol. 34, 743-748. (Pubitemid 37040608)
41. Gadang, V., Kohli, R., Myronovych, A., Hui, D.Y., Perez-Tilve, D., and Jaeschke, A. (2013). MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet. Am. J. Physiol. Endoc. Metab. 305, E549-556.
42. Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., Gordonov, S., et al. (2012). Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13, 1118-1128.
43. Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S.R., Jangamreddy, J.R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A.R., Kashani, H.H., et al. (2014). Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog. Neurobiol. 112, 24-49.
44. Gironella, M., Calvo, C., Fernández, A., Closa, D., Iovanna, J.L., Rosello-Catafau, J., and Folch-Puy, E. (2013). Reg3β deficiency impairs pancreatic tumor growth by skewing macrophage polarization. Cancer Res. 73, 5682-5694.
45. Gobeil, L.A., Lodge, R., and Tremblay, M.J. (2012). Differential HIV-1 endocytosis and susceptibility to virus infection in human macrophages correlate with cell activation status. J. Virol. 86, 10399-10407.
46. Goh, Y.P.S., Chawla, A., and Nguyen, K.D. (2011). Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 11, 738-749.
47. Gomez Perdiguero, E., and Geissmann, F. (2013). Myb-independent macrophages: a family of cells that develops with their tissue of residence and is involved in its homeostasis. Cold Spring Harb. Symp. Quant. Biol. [Epub ahead of print].
48. Gordon, S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
49. Hajizadeh, M.R., Mokarram, P., Kamali-Sarvestani, E., Bolhassani, A., and Mostafavi-Pour, Z. (2013). Recombinant nonstructural 3 protein, rNS3, of hepatitis C virus along with recombinant GP96 induce IL-12, TNFα and α5 integrin expression in antigen presenting cells. Hepat. Mon. 13, e8104.
50. Hanke, M.L., Heim, C.E., Angle, A., Sanderson, S.D., and Kielian, T. (2013). Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections. J. Immunol. 190, 2159-2168.
51. Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., Thaiss, C.A., Kau, A.L., Eisenbarth, S.C., Jurczak, M.J., et al. (2012). Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185.
52. Henao-Mejia, J., Elinav, E., Thaiss, C.A., and Flavell, R.A. (2013). Inflammasomes and metabolic disease. Annu. Rev. Physiol. [Epub ahead of print].
53. + Th1 cells. J. Immunol. 187, 1157-1165.
54. Heydtmann, M. (2009). Macrophages in hepatitis B and hepatitis C virus infections. J. Virol. 83, 2796-2802.
55. Hotamisligil, G.S. (2006). Inflammation and metabolic disorders. Nature 444, 860-867.
56. Hu, X., Chen, J., Wang, L., and Ivashkiv, L.B. (2007). Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J. Leukoc. Biol. 82, 237-243. (Pubitemid 47230632)
57. Huang, Z., Zhang, Z., Jiang, Y., Zhang, D., Chen, J., Dong, L., and Zhang, J. (2012). Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy. J. Control Release 158, 286-292.
58. Hume, D.A. (2008). Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol. 1, 432-441.
59. Jenner, R.G., and Young, R.A. (2005). Insights into host responses against pathogens from transcriptional profiling. Nat. Rev. Microbiol. 3, 281-294. (Pubitemid 40443722)
60. Ji, W.J., Ma, Y.Q., Zhou, X., Zhang, Y.D., Lu, R.Y., Sun, H.Y., Guo, Z.Z., Zhang, Z., Li, Y.M., and Wei, L.Q. (2013). Temporal and spatial characterization of mononuclear phagocytes in circulating, lung alveolar and interstitial compartments in a mouse model of bleomycin-induced pulmonary injury. J. Immunol. Methods pii: S0022-1759(13)00328-1.
61. Jouanguy, E., Döffinger, R., Dupuis, S., Pallier, A., Altare, F., and Casanova, J.L. (1999). IL-12 and IFN-γ in host defense against mycobacteria and salmonella in mice and men. Curr. Opin. Immunol. 11, 346-351.
62. Kadl, A., Meher, A.K., Sharma, P.R., Lee, M.Y., Doran, A.C., Johnstone, S.R., Elliot, M.R., Gruber, F., Han, J., Chen, W., et al. (2010). Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Cir. Res. 107, 737-746.
63. Kang, K., Reilly, S.M., Karabacak, V., Gangl, M.R., Fitzgerald, K., Hatano, B., and Lee, C.-H. (2008). Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 7, 485-495. (Pubitemid 351729204)
64. Kanneganti, T.D., and Dixit, V.D. (2012). Immunological complications of obesity. Nat. Immunol. 13, 707-712.
65. Karlmark, K.R., Weiskirchen, R., Zimmermann, H.W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., and Tacke, F. (2009). Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50, 261-274.
66. Kiszewski, A.E., Becerril, E., Aguilar, L.D., Kader, I.T.A., Myers, W., Portaels, F., and Hernàndez Pando, R. (2006). The local immune response in ulcerative lesions of Buruli disease. Clin. Exp. Immunol. 143, 445-451.
67. Klein, I., Cornejo, J.C., Polakos, N.K., John, B., Wuensch, S.A., Topham, D.J., Pierce, R.H., and Crispe, I.N. (2007). Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 110, 4077-4085. (Pubitemid 350248465)
68. Klimp, A.H., de Vries, E.G.E., Scherphof, G.L., and Daemen, T. (2002). A potential role of macrophage activation in the treatment of cancer. Crit. Rev. Oncol. Hematol. 44, 143-161. (Pubitemid 36159043)
69. Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., and Udalova, I.A. (2011). IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231-238.
70. Lavanchy, D. (2011). Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 17, 107-115.
71. Lawrence, T., and Natoli, G. (2011). Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750-761.
72. Leitinger, N., and Schulman, I.G. (2013). Phenotypic polarization of macrophages in atherosclerosis. Arterioscler. Throm. Vas. Biol. 33, 1120- 1126.
73. Leman, L.J., Maryanoff, B.E., and Ghadiri, M.R. (2013). Molecules that mimic apolipoprotein A-I: potential agents for treating Atherosclerosis. J. Med. Chem. (in press).
74. Liao, X., Sharma, N., and Kapadia, F. (2011). Krüppel-like factor 4 regulates macrophage polarization. J. Clin. Invest. 121, 2736-2749.
75. Liu, H., Perlman, H., Pagliari, L.J., and Pope, R.M. (2001). Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation. J. Exp. Med. 194, 113-126.
76. Liu, C.Y., Xu, J.Y., Shi, X.Y., Huang, W., Ruan, T.Y., Xie, P., and Ding, J.L. (2013). M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab. Invest. 93, 844-854.
77. Lugo-Villarino, G., Vérollet, C., Maridonneau-Parini, I., and Neyrolles, O. (2011). Macrophage polarization: convergence point targeted by Mycobacterium tuberculosis and HIV. Front. Immunol. 2, 43.
78. Lumeng, C.N., Bodzin, J.L., and Saltiel, A.R. (2007a). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184. (Pubitemid 46048464)
79. Lumeng, C.N., Deyoung, S.M., Bodzin, J.L., and Saltiel, A.R. (2007b). Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56, 16-23.
80. Luyendyk, J.P., Schabbauer, G.A., Tencati, M., Holscher, T., Pawlinski, R., and Mackman, N. (2008). Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J. Immunol. 180, 4218-4226.
81. Majai, G., Kiss, E., Tarr, T., Zahuczky, G., Hartman, Z., Szegedi, G., and Fésüs, L. (2014). Decreased apopto-phagocytic gene expression in the macrophages of systemic lupus erythematosus patients. Lupus 23, 133-145.
82. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686. (Pubitemid 39457982)
83. Mantovani, A., Biswas, S.K., Galdiero, M.R., Sica, A., and Locati, M. (2013). Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 229, 176-185.
84. Martinez, F.O., Sica, A., Mantovani, A., and Locati, M. (2008). Macrophage activation and polarization. Front. Biosci. 13, 453-461.
85. Martinez, F.O., Helming, L., and Gordon, S. (2009). Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483.
86. Mercalli, A., Calavita, I., Dugnani, E., Citro, A., Cantarelli, E., Nano, R., Melzi, R., Maffi, P., Secchi, A., Sordi, V., et al. (2013). Rapamycin unbalances the polarization of human macrophages to M1. Immunology 140, 179-190.
87. Mills, C.D., Kincaid, K., Alt, J.M., Heilman, M.J., and Hill, A.M. (2000). M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173. (Pubitemid 30408793)
88. Miura, K, Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J.M., Brenner, D.A., and Seki, E. (2010). Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1 beta in mice. Gastroenterology 139, 323-U453.
89. Miura, K., Yang, L., van Rooijen, N., Ohnishi, H., and Seki, E. (2012). Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G1310-G1321.
90. Miura, K., Yang, L., van Rooijen, N., Brenner, D.A., Ohnishi, H., and Seki, E. (2013). Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 57, 577-589.
91. Monini, P., Colombini, S., Stürzl, M., Goletti, D., Cafaro, A., Sgadari, C., Buttò, S., Franco, M., Leone, P., Fais, S., et al. (1999). Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 93, 4044-4058. (Pubitemid 29279246)
92. Moreno, J.L., Kaczmarek, M., Keegan, A.D., and Tondravi, M. (2003). IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood 102, 1078-1086. (Pubitemid 36917809)
93. Mosser, D. (2003). The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212.
94. Mosser, D.M., and Edwards, J.P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
95. Murray, P.J., and Wynn, T.A. (2011). Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737.
96. Mylonas, K.J., Nair, M.G., Prieto-Lafuente, L., Paape, D., and Allen, J.E. (2009). Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing. J. Immunol. 182, 3084-3094.
97. Nau, G.J., Richmond, J.F.L., Schlesinger, A., Jennings, E.G., Lander, E.S., and Young, R.A. (2002). Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 99, 1503-1508. (Pubitemid 34136522)
98. Neyen, C., Mukhopadhyay, S., Gordon, S., and Hagemann, T. (2013). An apolipoprotein A-I mimetic targets scavenger receptor A on tumor-associated macrophages: a prospective anticancer treatment? Oncoimmunology 2, e24461.
99. Niino, D., Komohara, Y., Murayama, T., Aoki, R., Kimura, Y., Hashikawa, K., Kiyasu, J., Takeuchi, M., Suefuji, N., Sugita, Y., et al. (2010). Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL). Pathol. Int. 60, 278-283.
100. Öberg, Å., Samii, S., Stenling, R., and Lindmark, G. (2002). Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors. Int. J. Colorectal Dis. 17, 25-29. (Pubitemid 41398987)
101. Obstfeld, A.E., Sugaru, E., Thearle, M., Francisco, A.M., Gayet, C., Ginsberg, H.N., Ables, E.V., and Ferrante, A.W. (2010). C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes 59, 916-925.
102. Odegaard, J.I., Ricardo-Gonzalez, R.R., Goforth, M.H., Morel, C.R., Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F., Ferrante, A.W., et al. (2007). Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447, 1116-1120. (Pubitemid 47014427)
103. Olefsky, J.M., and Glass, C.K. (2010). Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219-246.
104. Otto, M. (2008). Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 322, 207-228.
105. Paciello, I., Silipo, A., Lembo-fazio, L., Curcurù, L., Zumsteg, A., Noël, G., Ciancarella, V., Sturiale, L., Molinaro, A., and Bernardini, M.L. (2013). Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation. Proc. Natl. Acad. Sci. USA 110, E4345-4354.
106. Page, C., Goicochea, L., Matthews, K., Zhang, Y., Klover, P., Holtzman, M.J., Hennighausen, L., and Frieman, M. (2012). Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection. J. Virol. 86, 13334-13349.
107. Peiris, J.S.M., Chu, C.M., Cheng, V.C.C., Chan, K.S., Hung, I.F.N., Poon, L.L.M., Law, K.I., Tang, B.S., Hon, T.Y., Chan, C.S., et al. (2003). Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767-1772. (Pubitemid 36638424)
108. Poglitsch, M., Weichhart, T., Hecking, M., Werzowa, J., Katholnig, K., Antlanger, M., Krmpotic, A, Jonjic, S., Hörl, W.H., Zlabinger, G.J., et al. (2012). CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages. Am. J. Transplant. 12, 1458-1468.
109. Qin, H., Holdbrooks, A.T., Liu, Y., Reynolds, S.L., Yanagisawa, L.L., and Benveniste, E.N. (2012a). SOCS3 deficiency promotes M1 macrophage polarization and inflammation. J. Immunol. 189, 3439-3448.
110. Qin, H., Yeh, W.I., De Sarno, P., Holdbrooks, A.T., Liu, Y., Muldowney, M.T., Reynolds, S.L., Yanagisawa, L.L., Fox, T.H., Park, K., et al. (2012b). Signal transducer and activator of transcrip-tion- 3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proc. Natl. Acad. Sci. USA 109, 5004-5009.
111. Racanelli, V., and Rehermann, B. (2006). The liver as an immunological organ. Hepatology 43, S54-S62.
112. Raes, G., De Baetselier, P., Noël, W., Beschin, A., Brombacher, F., and Hassanzadeh Gh, G. (2002). Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 71, 597-602.
113. Raes, G., Van den Bergh, R., De Baetselier, P., Ghassabeh, G.H., Scotton, C., Locati, M., Mantovani, A., and Sozzani, S. (2005). Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J. Immunol. 174, 6561-6562.
114. Rauch, I., Müller, M., and Decker, T. (2013). The regulation of inflammation by interferons and their STATs. JAKSTAT 2, e23820.
115. Rawlings, J.S., Rosler, K.M., and Harrison, D.A. (2004). The JAK/STAT signaling pathway. J. Cell Sci. 117, 1281-1283. (Pubitemid 38559804)
116. Rius, B., López-Vicario, C., González-Périz, A., Morán-Salvador, E., García-Alonso, V., Clária, J., and Titos, E. (2012). Resolution of inflammation in obesity-induced liver disease. Front. Immunol. 3, 257.
117. Roh, Y.S., and Seki, E. (2013). Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J. Gastroenterol. Hepatol. 28, 38-42.
118. Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Sguadrito, M.L., Segura, I., Li, X., Knevels, E., et al. (2011). HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 19, 31-44.
119. Rottenberg, M.E., Gigliotti-Rothfuchs, A., and Wigzell, H. (2002). The role of IFN-gamma in the outcome of chlamydial infection. Curr. Opin. Immunol. 14, 444-451. (Pubitemid 34671246)
120. Schaale, K., Brandenburg, J., Kispert, A., Leitges, M., Ehlers, S., and Reiling, N. (2013). Wnt6 is expressed in granulomatous lesions of mycobacterium tuberculosis-infected mice and is involved in macrophage differentiation and proliferation. J. Immunol. 191, 5182-5195.
121. Schmieder, A., Michel, J., Schönhaar, K., Goerdt, S., and Schledzewski, K. (2012). Differentiation and gene expression profile of tumor-associated macrophages. Semin. Cancer. Biol. 22, 289-297.
122. Schulz, C., Gomez Perdiguero, E., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S.E., Pollard, J.W., et al. (2012). A lineage of myeloid cells independent of Myb and Hematopoietic stem cells. Science 336, 86-90.
123. Schwabe, R.F., and Brenner, D.A. (2006). Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G583-G589.
124. Schwabe, R.F., Seki, E., and Brenner, D.A. (2006). Toll-like receptor signaling in the liver. Gastroenterology 130, 1886-900. (Pubitemid 43668871)
125. Shanmugam, N., Gaw Gonzalo, I.T., and Natarajan, R. (2004). Molecular mechanisms of high glucose-induced cyclooxygena-se-2 expression in monocytes. Diabetes 53, 795-802. (Pubitemid 38270651)
126. Shaughnessy, L.M., and Swanson, J.A. (2007). The role of the activated macrophage in clearing Listeria monocytogenes infection. Front. Biosci. 12, 2683-2692.
127. Shirakawa, T., Kawazoe, Y., Tsujikawa, T., Jung, D., Sato, S., and Uesugi, M. (2011). Deactivation of STAT6 through serine 707 phosphorylation by JNK. J. Biol. Chem. 286, 4003-4010.
128. Sica, A., and Mantovani, A. (2012). Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 22, 787-795.
129. Sica, A., Saccani, A., and Mantovani, A. (2002). Tumor-associated macrophages: a molecular perspective. Int. Immunopharmacol. 2, 1045-1054.
130. Sica, A, Invernizzi, P., and Mantovani, A. (2013). Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology [In Press].
131. Smith, M., and Bentz, G. (2004a). Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 78, 4444-4453. (Pubitemid 38501064)
132. Smith, M., and Bentz, G. (2004b). HCMV activates PI (3) K in monocytes and promotes monocyte motility and transendothelial migration in a PI (3) K-dependent manner. J. Leukoc. Biol. 76, 65-76. (Pubitemid 38857173)
133. Song, Y., Dou, H., Gong, W., Liu, X., Yu, Z., Li, E., Tan, R., and Hou, Y. (2013). Bis-N-norgliovictin, a small-molecule compound from marine fungus, inhibits LPS-induced inflammation in macrophages and improves survival in sepsis. Eur. J. Pharmacol. 705, 49-60.
134. Stolfi, C., Caruso, R., Franzè, E., Sarra, M., De Nitto, D., Rizzo, A., Pallone, F., and Monteleone, G. (2011). Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages. Immunology 132, 66-77.
135. Stout, R.D., Jiang, C., Matta, B., Tietzel, I., Watkins, S.K., and Suttles, J. (2005). Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349. (Pubitemid 40884337)
136. Stout, R.D., and Suttles, J. (2004). Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76, 509-513. (Pubitemid 39129080)
137. Sun, K., Kusminski, C.M., and Scherer, P.E. (2011). Adipose tissue remodeling and obesity. J. Clin. Invest. 121, 2094-2101.
138. Sun, H., Sun, Y., Pu, J., Zhang, Y., Zhu, Q., Li, J., Gu, J., Chang, K. C., and Liu, J. (2013). Comparative virus replication and host innate response in human cells infected with 3 prevalent clades (2.3.4, 2.3.2 and 7) of highly pathogenic avian influenza H5N1 viruses. J. Virol. 88, 725-729.
139. Takai, H., Ashihara, M., Ishiguro, T., Terashima, H., Watanabe, T., Kato, A., and Suzuki, M. (2009a). Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma. Cancer Biol. Ther. 8, 2329-2338.
140. Takai, H., Kato, A., Kato, C., Watanabe, T., Matsubara, K., Suzuki, M., and Kataoka, H. (2009b). The expression profile of glypican- 3 and its relation to macrophage population in human hepatocellular carcinoma. Liver Int. 29, 1056-1064.
141. Tateya, S., Kim, F., and Tamori, Y. (2013). Recent advances in obesity-induced inflammation and insulin resistance. Front. Endocrinol. 4, 93.
142. Thomson, A.W., and Knolle, P.A. (2010). Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10, 753-766.
143. Thurlow, L.R., Hanke, M.L., Fritz, T., Angle, A., Aldrich, A., Williams, S.H., Engebretsen, I.L., Bayles, K.W., Horswill, A.R., and Kielian, T. (2011). Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 186, 6585-6596.
144. Tilg, H., and Moschen, A.R. (2010). Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836-1846.
145. Tosello-Trampont, A.C., Landes, S.G., Nguyen, V., Novobrantseva, T.I., and Hahn, Y.S. (2012). Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. J. Biol. Chem. 287, 40161-40172.
146. Umemura, N., Saio, M., Suwa, T., Kitoh, Y., Bai, J., Nonaka, K., Ouyang, G.F., Okada, M., Balazs, M., Adany, R., et al. (2008). Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J. Leukoc. Biol. 83, 1136-1144. (Pubitemid 351960345)
147. Verreck, F.A., de Boer, T., Langenberg, D.M., Hoeve, M.A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Wall-Malefyt, R., and Ottenhoff, T.H. (2004). Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101, 4560-4565. (Pubitemid 38437450)
148. Villares, R., Kakabadse, D., Juarranz, Y., Gomariz, R.P., Martínez-A.C., and Mellado, M. (2013). Growth hormone prevents the development of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 101, 4619-4627.
149. Wang, J., Li, F., Sun, R., Gao, X., Wei, H., Li, L.-J., and Tian, Z. (2013). Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages. Nat. Commun. 4, 2106.
150. Weichhart, T., and Säemann, M.D. (2008). The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann. Rheum. Dis. 67 Suppl 3, iii70-4.
151. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., and Ferrante, A.W. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808. (Pubitemid 38063703)
152. Weisberg, S.P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R.L., and Ferrante, A.W. (2006). CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115-124. (Pubitemid 43121796)
153. Wynn, T.A., Chawla, A., and Pollard, J.W. (2013). Macrophage biology in development, homeostasis and disease. Nature 496, 445-455.
154. Xu, H., Zhu, J., Smith, S., Foldi, J., Zhao, B., Chung, A.Y., Oultz, H., Kitajewski, J., Shi, C., Weber, S., et al. (2012). Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat. Immunol. 13, 642-650.
155. Xu, F., Kang, Y., Zhang, H., Piao, Z., Yin, H., Diao, R., Xia, J., and Shi, L. (2013). Akt1-mediated regulation of macrophage polarization in a murine model of Staphylococcus aureus pulmonary infection. J. Infect. Dis. 208, 528-538.
156. Yin, M.J., Yamamoto, Y., and Gaynor, R.B. (1998). The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396, 77-80. (Pubitemid 28520452)
157. You, Q., Holt, M., Yin, H., Li, G., Hu, C.-J., and Ju, C. (2013). Role of hepatic resident and infiltrating macrophages in liver repair after acute injury. Biochem. Pharmacol. 86, 836-843.
158. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.W., Karin, M., and Shoelson, S.E. (2001). Reversal of obesity- and dietinduced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673-1677. (Pubitemid 32807849)
159. Zhou, Q., Peng, R.-Q., Wu, X.-J., Xia, Q., Hou, J.-H., Ding, Y., Zhou, Q.M., Zhang, X., Pang, Z.Z., Wan, D.S., et al. (2010). The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J. Transl. Med. 8, 13.
160. Zhou, D., Huang, C., Lin, Z., Zhan, S., Kong, L., Fang, C., and Li, J. (2013). Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell. Signal. 26, 192-197.
161. Zhu, L., Baker, S.S., Gill, C., Liu, W., Alkhouri, R., Baker, R.D., and Gill, S.R. (2013). Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57, 601-609.